Principal Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$178M Buy
6,339,372
+32,564
+0.5% +$867K 0.1% 196
2025
Q4
$157M Buy
6,306,808
+169,048
+3% +$4.26M 0.08% 215
2025
Q3
$156M Sell
6,137,760
-52,625
-0.9% -$1.3M 0.08% 217
2025
Q2
$150M Sell
6,190,385
-181,263
-3% -$4.23M 0.08% 215
2025
Q1
$161M Sell
6,371,648
-32,231
-0.5% -$843K 0.09% 200
2024
Q4
$170M Sell
6,403,879
-2,684,440
-30% -$72.8M 0.09% 193
2024
Q3
$263M Sell
9,088,319
-1,349,308
-13% -$39.4M 0.14% 142
2024
Q2
$292M Sell
10,437,627
-657,172
-6% -$18.1M 0.17% 122
2024
Q1
$308M Sell
11,094,799
-47,467
-0.4% -$1.32M 0.18% 119
2023
Q4
$321M Sell
11,142,266
-693,695
-6% -$21M 0.2% 109
2023
Q3
$393M Sell
11,835,961
-72,872
-0.6% -$2.58M 0.28% 83
2023
Q2
$437M Buy
11,908,833
+218,037
+2% +$8.49M 0.3% 80
2023
Q1
$477M Buy
11,690,796
+97,672
+0.8% +$4.22M 0.34% 69
2022
Q4
$594M Sell
11,593,124
-185,484
-2% -$8.89M 0.45% 49
2022
Q3
$515M Buy
11,778,608
+3,751
+0% +$182K 0.41% 54
2022
Q2
$617M Buy
11,774,857
+566,590
+5% +$28.9M 0.46% 46
2022
Q1
$580M Buy
11,208,267
+185,005
+2% +$9.6M 0.37% 61
2021
Q4
$650M Sell
11,023,262
-1,546,449
-12% -$76.6M 0.39% 54
2021
Q3
$541M Buy
12,569,711
+801,981
+7% +$35.5M 0.35% 60
2021
Q2
$461M Buy
11,767,730
+426,033
+4% +$16.6M 0.3% 82
2021
Q1
$411M Sell
11,341,697
-549,449
-5% -$19.5M 0.29% 89
2020
Q4
$438M Sell
11,891,146
-1,446,387
-11% -$53.1M 0.32% 83
2020
Q3
$464M Sell
13,337,533
-798,743
-6% -$28M 0.39% 58
2020
Q2
$439M Buy
14,136,276
+619,112
+5% +$21M 0.39% 59
2020
Q1
$419M Sell
13,517,164
-32,581
-0.2% -$1.11M 0.46% 45
2019
Q4
$504M Sell
13,549,745
-314,468
-2% -$11.2M 0.42% 45
2019
Q3
$473M Sell
13,864,213
-316,835
-2% -$11.5M 0.42% 47
2019
Q2
$583M Sell
14,181,048
-855,518
-6% -$34M 0.52% 32
2019
Q1
$606M Sell
15,036,566
-512,762
-3% -$20.5M 0.56% 27
2018
Q4
$644M Sell
15,549,328
-567,183
-4% -$23.5M 0.69% 18
2018
Q3
$674M Sell
16,116,511
-549,350
-3% -$21.1M 0.59% 23
2018
Q2
$574M Buy
16,665,861
+713,556
+4% +$24.4M 0.53% 28
2018
Q1
$537M Buy
15,952,305
+157,200
+1% +$5.4M 0.51% 29
2017
Q4
$543M Buy
15,795,105
+193,736
+1% +$6.61M 0.5% 29
2017
Q3
$528M Buy
15,601,369
+196,877
+1% +$6.33M 0.51% 28
2017
Q2
$491M Buy
15,404,492
+4,916,770
+47% +$155M 0.49% 29
2017
Q1
$340M Sell
10,487,722
-1,660,513
-14% -$52.4M 0.41% 47
2016
Q4
$374M Sell
12,148,235
-2,763,233
-19% -$84.4M 0.47% 36
2016
Q3
$479M Buy
14,911,468
+460,250
+3% +$15.4M 0.63% 21
2016
Q2
$483M Sell
14,451,218
-3,311,669
-19% -$106M 0.67% 16
2016
Q1
$500M Buy
17,762,887
+503,791
+3% +$14.4M 0.72% 10
2015
Q4
$529M Buy
17,259,096
+2,242,040
+15% +$70.5M 0.79% 11
2015
Q3
$448M Buy
15,017,056
+140,827
+0.9% +$4.52M 0.7% 12
2015
Q2
$473M Sell
14,876,229
-2,698,078
-15% -$87.9M 0.71% 11
2015
Q1
$580M Sell
17,574,307
-699,324
-4% -$22.2M 0.86% 8
2014
Q4
$540M Buy
18,273,631
+1,499,885
+9% +$43M 0.84% 7
2014
Q3
$471M Buy
16,773,746
+1,214,481
+8% +$34.1M 0.8% 9
2014
Q2
$438M Buy
15,559,265
+1,033,640
+7% +$29.5M 0.74% 9
2014
Q1
$443M Buy
14,525,625
+3,853,016
+36% +$115M 0.79% 8
2013
Q4
$310M Sell
10,672,609
-141,950
-1% -$4.13M 0.58% 15
2013
Q3
$295M Buy
10,814,559
+1,173,435
+12% +$31.9M 0.61% 15
2013
Q2
$256M Buy
+9,641,124
New +$266M 0.57% 20

Other funds holding PFE

Principal Financial Group's PFE Position: Q1 2026 in Review

Principal Financial Group increased its Pfizer (PFE) stake by 0.52% in Q1 2026, buying an estimated $867K and bringing the position to 6,339,372 shares worth $178M. The position accounts for 0.1% of the portfolio, ranked #196.

Principal Financial Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $674M in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Principal Financial Group held 6,339,372 shares of Pfizer worth $178M as of Q1 2026.
  • Principal Financial Group bought 32,564 Pfizer shares in Q1 2026, an estimated $867K.
  • Pfizer made up 0.1% of Principal Financial Group's portfolio in Q1 2026, its #196 holding.
  • Principal Financial Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Principal Financial Group's Pfizer position peaked at $674M in Q3 2018.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.